FAP and gastric cancer: Nevertheless, we concentrated on a specific group of patients and verified the clinical values of CAFs biomarkers, including CD10, FAP and GPR77 in locally advanced gastric cancer patients who underwent NCT, and explored the association of these biomarkers with drug resistance and prognosis.